Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Lineage Cell Therapeutics Inc
LCTX
Healthcare
Biotechnology
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs. The Company’s programs are based on its cell-based technology platform and associated development and manufacturing capabilities. From this platform, the Company designs, develops, manufactures, and tests specialized human cells with anatomical and...
physiological functions. Its neuroscience focused pipeline includes OpRegen, a retinal pigment epithelial cell therapy in phase II a development, for the treatment of geographic atrophy secondary to age-related macular degeneration; OPC1, an oligodendrocyte progenitor cell therapy in phase I/II a development for the treatment of spinal cord injuries; ANP1, an auditory neuronal progenitor cell therapy for the potential treatment of auditory neuropathy; PNC1, a photoreceptor neural cell therapy for the potential treatment of vision loss due to photoreceptor dysfunction or damage; and RND1.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NYSEAM:LCTX)
New Post
View:
Posts & Comments
Threaded Posts
(39)
•••
Teccing
X
View Profile
View Bullboard History
Comment by
Teccing
on Mar 27, 2024 12:35pm
RE:Lineage Cell Therapeutics Announces Closing of $14.0 Million
Why the bounce today?
(85)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Feb 09, 2024 2:15pm
Lineage Cell Therapeutics Announces Closing of $14.0 Million
NEWS: $LCTX Lineage Cell Therapeutics Announces Closing of $14.0 Million Registered Direct OfferingLineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology
...more
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project
posted May 01, 2024 9:00am by
Viva Gold Corp.
-
|
Previously unknown areas of gold mineralization were discovered with longer lengths and higher gold grades than expected. 21.3 meters at 5.1 gpt Au was drilled as an approximate 40-meter offset to the west of TG2211 (57.9-meters at 5.0 gpt Au commencing at 40-meters depth). James Hesketh, President & CEO stated, “Many geologists go their whole careers without seeing drill results like these ...read more
(144)
•••
unclepieman
X
View Profile
View Bullboard History
Post by
unclepieman
on Jan 11, 2021 4:16pm
starting to look really good!
So we have a catalyst Q1/Q2 2021 on Dry AMD. A $10B market with no solution and LCTX might be the answer! I'm Long in BTI.V, LCTX, GERN, SLS, ICO.v, MMIRF, TNDM and recently went Long on
...more
(9)
•••
schoolofrock
X
View Profile
View Bullboard History
Post by
schoolofrock
on Nov 10, 2020 10:37am
TODAY 1PM - Meet CEO Brian Culley and CFO Brandi Roberts
**TODAY** - Nov 10th - virtual road show today with CEO Brian Culley and CFO Brandi Roberts. Register at no charge: https://attendee.gotowebinar.com/register/5866089557613760267
(9)
•••
schoolofrock
X
View Profile
View Bullboard History
Post by
schoolofrock
on Nov 03, 2020 8:01am
Nov 10th - Meet CEO Brian Culley and CFO Brandi Roberts
Mark your calendar - Nov 10th - virtual road show a week from today with CEO Brian Culley and CFO Brandi Roberts. Register at no charge: https://attendee.gotowebinar.com/register/5866089557613760267
(9)
•••
schoolofrock
X
View Profile
View Bullboard History
Post by
schoolofrock
on Oct 14, 2020 9:50am
LCTX - Early VAC2 Data Shows Promise
Lineage disclosed data from the Phase 1 clinical study of VAC2 for the treatment of non-small cell lung cancer (NSCLC), sponsored by partner Cancer Research UK (CR UK). The results showed ... https:/
...more
(9)
•••
schoolofrock
X
View Profile
View Bullboard History
Post by
schoolofrock
on Sep 17, 2020 10:40am
Noble Capital Markets initiates coverage
Research report released. See: https://www.channelchek.com/news-channel/Lineage_Cell_Therapeutics__LCTX____Initiating_Coverage__Eye_of_Stem_Cell_Treatments_and_Beyond
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up